Theoretical dissolution model of poly-disperse drug particles in biorelevant media.

The purpose of the present study was to construct the theoretical dissolution model of poly-disperse drug particles in biorelevant media containing bile salt/ lecithin aggregates (micelles or vesicles). The effective diffusion coefficient in the biorelevant medium and the particle size distribution of drug particles were simultaneously factored into the Nernst-Brunner equation. The effective diffusion coefficient of a drug in the biorelevant medium was calculated to be smaller than that in the blank buffer, since the diffusion coefficient of a drug bound to the aggregates became similar to that of the aggregates. The particle size distribution of a drug powder was simulated as the sum of mono-disperse fractions covering the particle size range. To verify the modified equation, the dissolution profile of griseofulvin and danazol in a taurocholic acid/egg lecithin (4:1 mixture, taurocholic acid = 0-30 mM) system was investigated. It was clearly demonstrated that both modifications on the Nernst-Brunner equation improved the prediction accuracy. When the effect of the particle size distribution was neglected, the theoretical curve underestimated the observed value at the early phase of dissolution process. When the diffusion coefficient of a free drug was used instead of the effective diffusion coefficient, the theoretical curve overestimated the observed value. The results of the present study suggested that the effect of the particle size distribution and the effective diffusion coefficient should be taken into consideration.

[1]  M. Kozlov,et al.  Phase boundaries in mixtures of membrane-forming amphiphiles and micelle-forming amphiphiles. , 2000, Biochimica et biophysica acta.

[2]  Y. Masaoka,et al.  Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system. , 2006, Journal of pharmaceutical sciences.

[3]  J. Delaney Predicting aqueous solubility from structure. , 2005, Drug discovery today.

[4]  E. Kerns,et al.  High throughput physicochemical profiling for drug discovery. , 2001, Journal of pharmaceutical sciences.

[5]  Hans Lennernäs,et al.  The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.

[6]  Martin Kuentz,et al.  A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  T. Nagai,et al.  Prediction of available surface area of powdered particles of flufenamic acid in tablets. , 1985, Chemical & pharmaceutical bulletin.

[8]  Kiyohiko Sugano,et al.  High throughput solubility measurement with automated polarized light microscopy analysis. , 2006, Journal of pharmaceutical sciences.

[9]  Thierry Lavé,et al.  Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  J. Dressman,et al.  Comparison of the Mechanism of Dissolution of Hydrocortisone in Simple and Mixed Micelle Systems , 1993, Pharmaceutical Research.

[11]  Christos Reppas,et al.  Biorelevant Dissolution Testing to Predict the Plasma Profile of Lipophilic Drugs After Oral Administration , 2001, Pharmaceutical Research.

[12]  Panos Macheras,et al.  A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.

[13]  Anette Müllertz,et al.  In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  R. Löbenberg,et al.  Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.

[15]  C. Larive,et al.  A mechanistic study of danazol dissolution in ionic surfactant solutions. , 2003, Journal of pharmaceutical sciences.

[16]  H. Kristensen,et al.  Biorelevant dissolution media: aggregation of amphiphiles and solubility of estradiol. , 2006, Journal of pharmaceutical sciences.

[17]  Kiyohiko Sugano,et al.  Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution Test , 2006, Pharmaceutical Research.

[18]  C. Larive,et al.  A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions. , 1997, Journal of pharmaceutical sciences.

[19]  N. Kaniwa,et al.  Effect of food on the bioavailability of griseofulvin from microsize and PEG ultramicrosize (GRIS-PEG) plain tablets. , 1982, Journal of pharmacobio-dynamics.

[20]  R. J. Hintz,et al.  The effect of particle size distribution on dissolution rate and oral absorption , 1989 .

[21]  C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[22]  J. Legendre,et al.  Determination of the Aqueous Solubility of Drugs Using a Convenient 96-Well Plate-Based Assay , 2001, Drug development and industrial pharmacy.

[23]  Kouki Obata,et al.  Processing of Biopharmaceutical Profiling Data in Drug Discovery , 2007 .

[24]  C. Bevan,et al.  A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. , 2000, Analytical chemistry.

[25]  W. Nernst,et al.  Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .

[26]  Anand Balakrishnan,et al.  Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity. , 2004, Journal of pharmaceutical sciences.

[27]  M. Machida,et al.  Biopharmaceutics Classification by High Throughput Solubility Assay and PAMPA , 2004, Drug development and industrial pharmacy.

[28]  P. Harriott Mass transfer to particles: Part I. Suspended in agitated tanks , 1962 .

[29]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[30]  T. Nagai,et al.  Effect of compression pressure and formulation on the available surface area of flufenamic acid in tablets. , 1986, Chemical & pharmaceutical bulletin.

[31]  T. Nagai,et al.  Dissolution profiles of nalidixic acid powders having Weibull particle size distribution. , 1985, Chemical and pharmaceutical bulletin.

[32]  M. Odomi,et al.  Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Vinod P. Shah,et al.  Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions , 2002, Pharmaceutical Research.

[34]  Alex Avdeef,et al.  Physicochemical Profiling (Solubility, Permeability and Charge State) , 2001 .

[35]  M. Rogge,et al.  Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability , 1993, Journal of clinical pharmacology.

[36]  A. Glomme,et al.  Predicting the Intestinal Solubility of Poorly Soluble Drugs , 2007 .

[37]  Christos Reppas,et al.  Forecasting the In Vivo Performance of Four Low Solubility Drugs from Their In Vitro Dissolution Data , 1999, Pharmaceutical Research.

[38]  S Chakrabarti,et al.  Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow. 1. Effect of tablet geometry in buffered medium. , 1996, Journal of pharmaceutical sciences.

[39]  Kevin C. Johnson,et al.  Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.

[40]  S Chakrabarti,et al.  Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow. 2. Cocompression of drugs with buffers. , 1997, Journal of pharmaceutical sciences.